Matches in Wikidata for { <http://www.wikidata.org/entity/Q92119300> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- Q92119300 description "article scientifique publié en 2020" @default.
- Q92119300 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92119300 description "scientific article published on 08 January 2020" @default.
- Q92119300 description "wetenschappelijk artikel" @default.
- Q92119300 description "наукова стаття, опублікована 8 січня 2020" @default.
- Q92119300 name "Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target" @default.
- Q92119300 name "Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target" @default.
- Q92119300 type Item @default.
- Q92119300 label "Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target" @default.
- Q92119300 label "Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target" @default.
- Q92119300 prefLabel "Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target" @default.
- Q92119300 prefLabel "Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target" @default.
- Q92119300 P1433 Q92119300-85BC8019-6A00-4919-AF70-BEF8ADB96AEC @default.
- Q92119300 P1476 Q92119300-21A1377F-A3D2-4EB7-9A98-8554CAFEA877 @default.
- Q92119300 P2093 Q92119300-0C56A445-EF5F-45B6-BB9D-DD09ADB325B4 @default.
- Q92119300 P2093 Q92119300-0F690111-3C85-44DA-9BE5-A59DEF55722A @default.
- Q92119300 P2093 Q92119300-1747382D-8FDD-4D54-93A9-FE932027D1E5 @default.
- Q92119300 P2093 Q92119300-291E4A6E-C977-4C71-95BA-89D530F21957 @default.
- Q92119300 P2093 Q92119300-307360E5-6E74-4295-93AB-C635FCEC9D85 @default.
- Q92119300 P2093 Q92119300-37F7E4EE-D08A-4F42-A7E3-5CE2D2AEF8D4 @default.
- Q92119300 P2093 Q92119300-3B0E56C8-DA63-467B-8042-FB871B77EFD7 @default.
- Q92119300 P2093 Q92119300-3B42C4D6-CE8E-47DB-BDD8-58FD879030C1 @default.
- Q92119300 P2093 Q92119300-429B335B-A6DC-4B14-917A-C82C1783840C @default.
- Q92119300 P2093 Q92119300-4B473840-65E1-4A36-8D33-8A0D03608884 @default.
- Q92119300 P2093 Q92119300-58B40ACE-E705-4AE0-A0FB-542E346D4800 @default.
- Q92119300 P2093 Q92119300-6216E6E0-8DD5-4AFC-9471-C10FBD7B03B1 @default.
- Q92119300 P2093 Q92119300-6B70BA27-820F-4358-A94C-BBC7A8F758D9 @default.
- Q92119300 P2093 Q92119300-830DA790-8FB2-48C1-B867-CF381C08B5E6 @default.
- Q92119300 P2093 Q92119300-9DACB117-2222-4BE2-B38B-5FA0EB2D3FC3 @default.
- Q92119300 P2093 Q92119300-A9611A04-EA25-4C85-BC44-33E7B3493416 @default.
- Q92119300 P2093 Q92119300-B62F9AAE-B0A1-4B05-9710-C3DA6773C328 @default.
- Q92119300 P2093 Q92119300-C6BFB86A-07A8-4D37-8FEE-A923469F4C99 @default.
- Q92119300 P2093 Q92119300-DC9D76C0-309D-4E83-9051-F5A7879F3229 @default.
- Q92119300 P2093 Q92119300-E239F8DC-43D6-4B30-89E0-08AFFE42851F @default.
- Q92119300 P2093 Q92119300-E83B9FFF-630E-415E-B310-E7ED923E7AAF @default.
- Q92119300 P304 Q92119300-CAD0D3D1-F39A-42A1-AA01-66BBA49CE914 @default.
- Q92119300 P31 Q92119300-C27B8CA2-E7A5-41F5-BC89-BBEE27328E3B @default.
- Q92119300 P356 Q92119300-DED3FEEB-EA18-4A18-B5AF-3B0879FBAE2E @default.
- Q92119300 P433 Q92119300-5BC84A1F-A41C-4043-A621-7519A7FD0A75 @default.
- Q92119300 P478 Q92119300-DAE001ED-1240-48E3-A4CC-19C73D4C675A @default.
- Q92119300 P50 Q92119300-22C286A7-AE8F-4CA3-80FC-36707CC8B1D2 @default.
- Q92119300 P50 Q92119300-AAF1182E-9F3E-4174-B630-CEFBE5CF67C9 @default.
- Q92119300 P50 Q92119300-C225526F-1D29-436E-8F12-4B595495BB48 @default.
- Q92119300 P50 Q92119300-F17D1997-FF10-4B32-85BD-D42220C3762E @default.
- Q92119300 P577 Q92119300-259B5F1F-3E14-4FF6-9860-E6B0B5499EB4 @default.
- Q92119300 P698 Q92119300-8B7A4C5B-1EBC-48B2-AFD2-89C668427570 @default.
- Q92119300 P356 ACS.JMEDCHEM.9B01585 @default.
- Q92119300 P698 31855425 @default.
- Q92119300 P1433 Q900316 @default.
- Q92119300 P1476 "Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target" @default.
- Q92119300 P2093 "Aoife Maxwell" @default.
- Q92119300 P2093 "Augustin Amour" @default.
- Q92119300 P2093 "Birgit Dümpelfeld" @default.
- Q92119300 P2093 "Chris D Edwards" @default.
- Q92119300 P2093 "Christina Rau" @default.
- Q92119300 P2093 "Daniel A Thomas" @default.
- Q92119300 P2093 "David Mallett" @default.
- Q92119300 P2093 "Edith M Hessel" @default.
- Q92119300 P2093 "Friedrich B M Reinhard" @default.
- Q92119300 P2093 "J Nicole Hamblin" @default.
- Q92119300 P2093 "James Rowedder" @default.
- Q92119300 P2093 "Jonathan A Taylor" @default.
- Q92119300 P2093 "Mark Price" @default.
- Q92119300 P2093 "Máire Convery" @default.
- Q92119300 P2093 "Nick Barton" @default.
- Q92119300 P2093 "Paola Grandi" @default.
- Q92119300 P2093 "Paul M Gore" @default.
- Q92119300 P2093 "Paul Rowland" @default.
- Q92119300 P2093 "Stefano Livia" @default.
- Q92119300 P2093 "Steve Keeling" @default.
- Q92119300 P2093 "Zoë A Henley" @default.
- Q92119300 P304 "638-655" @default.
- Q92119300 P31 Q13442814 @default.
- Q92119300 P356 "10.1021/ACS.JMEDCHEM.9B01585" @default.
- Q92119300 P433 "2" @default.
- Q92119300 P478 "63" @default.
- Q92119300 P50 Q53370297 @default.
- Q92119300 P50 Q57196241 @default.
- Q92119300 P50 Q90378734 @default.
- Q92119300 P50 Q90483693 @default.
- Q92119300 P577 "2020-01-08T00:00:00Z" @default.
- Q92119300 P698 "31855425" @default.